Guru Ownership Trend
Guru Analysis for Telix Pharmaceuticals Limited (TLX)
Telix Pharmaceuticals Limited (TLX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 1 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $198,264.93.
Top institutional holders include Steven Cohen.
Institutional sentiment is currently Bullish. This is evidenced by a $137,883 net inflow during the quarter.
Recent activity highlights Steven Cohen who opened a new position.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Telix Pharmaceuticals Limited (TLX)
Major holders include Steven Cohen ($137,883). According to the latest reported data, 1 tracked investment managers collectively hold approximately 18,409 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $137,883, with 1 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in TLX during the most recent reporting period.
Yes, 1 managers opened new positions in TLX, and 0 increased their existing holdings. The total reported buy value was $137,883.